IFN-α mediates the up-regulation of HLA class I on melanoma cells without switching proteasome to immunoproteasome

Giuliana Cangemi, Barbara Morandi, Antonella D'Agostino, Cristiano Peri, Romana Conte, Gianluca Damonte, Guido Ferlazzo, Roberto Biassoni, Giovanni Melioli

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Treatment of melanoma cell lines with IFN-γ induces the switch from proteasome (PS) to immunoproteasome (iPS). This finding has profound implications for the immunobiology of melanoma cells since certain peptides (such as Melan-Amart1 27-35) are cleaved differently by iPS, thus implying a different ability to be presented by HLA class I molecules. IFN-α is a cytokine not only produced during infectious diseases, but also used in the treatment of certain cancers. Nevertheless, the effects of IFN-α on the switch of PS to WS are largely unknown. A comparison of the effect of both IFN-α and IFN-γ was thus carried out on melanoma cell lines. RT-PCR showed that mRNA for iPS subunits (i.e. LMP-2, LMP-7 and MECL-1) was detectable both in untreated and IFN-treated melanoma cells. Immunoblotting analysis revealed that while IFN-γ was able to consistently induce the switch from PS to iPS, IFN-α treatment did not, possibly due to post-transcriptional event(s) blocking the expression of iPS-specific subunits. Finally, Melan-Amart1 27-35 peptide was found only in the HPLC-MS spectra from both untreated and IFN-α-treated cells, but not upon IFN-γ treatment. Altogether, these data demonstrate that IFN-α does not induce the switch from PS to iPS.

Original languageEnglish
Pages (from-to)1415-1421
Number of pages7
JournalInternational Immunology
Volume15
Issue number12
DOIs
Publication statusPublished - Dec 2003

Fingerprint

Proteasome Endopeptidase Complex
Melanoma
Up-Regulation
Cell Line
Peptides
Immunoblotting
Communicable Diseases
High Pressure Liquid Chromatography
Cytokines
Polymerase Chain Reaction
Messenger RNA
Neoplasms

Keywords

  • HLA
  • IFN
  • Peptide
  • Proteasome

ASJC Scopus subject areas

  • Immunology

Cite this

IFN-α mediates the up-regulation of HLA class I on melanoma cells without switching proteasome to immunoproteasome. / Cangemi, Giuliana; Morandi, Barbara; D'Agostino, Antonella; Peri, Cristiano; Conte, Romana; Damonte, Gianluca; Ferlazzo, Guido; Biassoni, Roberto; Melioli, Giovanni.

In: International Immunology, Vol. 15, No. 12, 12.2003, p. 1415-1421.

Research output: Contribution to journalArticle

Cangemi, Giuliana ; Morandi, Barbara ; D'Agostino, Antonella ; Peri, Cristiano ; Conte, Romana ; Damonte, Gianluca ; Ferlazzo, Guido ; Biassoni, Roberto ; Melioli, Giovanni. / IFN-α mediates the up-regulation of HLA class I on melanoma cells without switching proteasome to immunoproteasome. In: International Immunology. 2003 ; Vol. 15, No. 12. pp. 1415-1421.
@article{e808047226974316bcbf20128dc07271,
title = "IFN-α mediates the up-regulation of HLA class I on melanoma cells without switching proteasome to immunoproteasome",
abstract = "Treatment of melanoma cell lines with IFN-γ induces the switch from proteasome (PS) to immunoproteasome (iPS). This finding has profound implications for the immunobiology of melanoma cells since certain peptides (such as Melan-Amart1 27-35) are cleaved differently by iPS, thus implying a different ability to be presented by HLA class I molecules. IFN-α is a cytokine not only produced during infectious diseases, but also used in the treatment of certain cancers. Nevertheless, the effects of IFN-α on the switch of PS to WS are largely unknown. A comparison of the effect of both IFN-α and IFN-γ was thus carried out on melanoma cell lines. RT-PCR showed that mRNA for iPS subunits (i.e. LMP-2, LMP-7 and MECL-1) was detectable both in untreated and IFN-treated melanoma cells. Immunoblotting analysis revealed that while IFN-γ was able to consistently induce the switch from PS to iPS, IFN-α treatment did not, possibly due to post-transcriptional event(s) blocking the expression of iPS-specific subunits. Finally, Melan-Amart1 27-35 peptide was found only in the HPLC-MS spectra from both untreated and IFN-α-treated cells, but not upon IFN-γ treatment. Altogether, these data demonstrate that IFN-α does not induce the switch from PS to iPS.",
keywords = "HLA, IFN, Peptide, Proteasome",
author = "Giuliana Cangemi and Barbara Morandi and Antonella D'Agostino and Cristiano Peri and Romana Conte and Gianluca Damonte and Guido Ferlazzo and Roberto Biassoni and Giovanni Melioli",
year = "2003",
month = "12",
doi = "10.1093/intimm/dxg140",
language = "English",
volume = "15",
pages = "1415--1421",
journal = "International Immunology",
issn = "0953-8178",
publisher = "Oxford University Press",
number = "12",

}

TY - JOUR

T1 - IFN-α mediates the up-regulation of HLA class I on melanoma cells without switching proteasome to immunoproteasome

AU - Cangemi, Giuliana

AU - Morandi, Barbara

AU - D'Agostino, Antonella

AU - Peri, Cristiano

AU - Conte, Romana

AU - Damonte, Gianluca

AU - Ferlazzo, Guido

AU - Biassoni, Roberto

AU - Melioli, Giovanni

PY - 2003/12

Y1 - 2003/12

N2 - Treatment of melanoma cell lines with IFN-γ induces the switch from proteasome (PS) to immunoproteasome (iPS). This finding has profound implications for the immunobiology of melanoma cells since certain peptides (such as Melan-Amart1 27-35) are cleaved differently by iPS, thus implying a different ability to be presented by HLA class I molecules. IFN-α is a cytokine not only produced during infectious diseases, but also used in the treatment of certain cancers. Nevertheless, the effects of IFN-α on the switch of PS to WS are largely unknown. A comparison of the effect of both IFN-α and IFN-γ was thus carried out on melanoma cell lines. RT-PCR showed that mRNA for iPS subunits (i.e. LMP-2, LMP-7 and MECL-1) was detectable both in untreated and IFN-treated melanoma cells. Immunoblotting analysis revealed that while IFN-γ was able to consistently induce the switch from PS to iPS, IFN-α treatment did not, possibly due to post-transcriptional event(s) blocking the expression of iPS-specific subunits. Finally, Melan-Amart1 27-35 peptide was found only in the HPLC-MS spectra from both untreated and IFN-α-treated cells, but not upon IFN-γ treatment. Altogether, these data demonstrate that IFN-α does not induce the switch from PS to iPS.

AB - Treatment of melanoma cell lines with IFN-γ induces the switch from proteasome (PS) to immunoproteasome (iPS). This finding has profound implications for the immunobiology of melanoma cells since certain peptides (such as Melan-Amart1 27-35) are cleaved differently by iPS, thus implying a different ability to be presented by HLA class I molecules. IFN-α is a cytokine not only produced during infectious diseases, but also used in the treatment of certain cancers. Nevertheless, the effects of IFN-α on the switch of PS to WS are largely unknown. A comparison of the effect of both IFN-α and IFN-γ was thus carried out on melanoma cell lines. RT-PCR showed that mRNA for iPS subunits (i.e. LMP-2, LMP-7 and MECL-1) was detectable both in untreated and IFN-treated melanoma cells. Immunoblotting analysis revealed that while IFN-γ was able to consistently induce the switch from PS to iPS, IFN-α treatment did not, possibly due to post-transcriptional event(s) blocking the expression of iPS-specific subunits. Finally, Melan-Amart1 27-35 peptide was found only in the HPLC-MS spectra from both untreated and IFN-α-treated cells, but not upon IFN-γ treatment. Altogether, these data demonstrate that IFN-α does not induce the switch from PS to iPS.

KW - HLA

KW - IFN

KW - Peptide

KW - Proteasome

UR - http://www.scopus.com/inward/record.url?scp=0346147029&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0346147029&partnerID=8YFLogxK

U2 - 10.1093/intimm/dxg140

DO - 10.1093/intimm/dxg140

M3 - Article

C2 - 14645150

AN - SCOPUS:0346147029

VL - 15

SP - 1415

EP - 1421

JO - International Immunology

JF - International Immunology

SN - 0953-8178

IS - 12

ER -